Opioid Rx Down, but Overdoses and Deaths Up, AMA Report Shows
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 15, 2023 -- Opioid prescribing by physicians and other health professionals has decreased for the 13th consecutive year, down nearly 50 percent since 2012, while overdoses and deaths related to illicitly manufactured fentanyl, xylazine, and other synthetic substances continue to increase, according to the Overdose Epidemic Report 2023, released by the American Medical Association (AMA).
In 2022, more than 107,000 people died from a drug-related overdose in the United States, with the epidemic increasingly impacting young people, Black and Brown people, and pregnant people. Since 2018, naloxone dispensing has increased more than 200 percent, and buprenorphine dispensed by community pharmacies for the treatment of opioid use disorder (OUD) nearly doubled in the past 10 years.
The AMA calls for action on eight strategies to remove barriers and increase patients' access to evidence-based care for OUD, including take-home medications, telehealth options, and care for justice-involved persons. Additionally, the AMA calls for making nonopioid pain care alternatives more accessible and affordable and meeting social determinants of health needs. Other recommendations include the enforcement of mental health parity laws and increasing harm reduction resources such as naloxone, syringe services programs, and fentanyl test strips.
"Naloxone is one success story we've seen this year because access to opioid-overdose reversal medications continues to save tens of thousands of lives," Bobby Mukkamala, M.D., chair of the AMA Substance Use and Pain Care Task Force, said in a statement. "Unfortunately, we are at a place where naloxone needs to be available as easily as a first aid kit or a defibrillator in public spaces."
AMA Overdose Epidemic Report 2023
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Rapid Procedure Noninferior for Extended-Release Naltrexone Initiation
THURSDAY, May 9, 2024 -- For patients with opioid use disorder (OUD), a rapid procedure (RP) is noninferior to a standard procedure for initiation of extended-release (XR)...
321,566 Children Lost a Parent to Drug Overdose in 2011 to 2021
WEDNESDAY, May 8, 2024 -- From 2011 to 2021, an estimated 321,566 children lost a parent to drug overdose in the United States, according to a study published online May 8 in JAMA...
Elimination of Buprenorphine Waiver Had Moderate Effect
MONDAY, May 6, 2024 -- Elimination of the buprenorphine waiver increased the number of prescribers, but only modestly increased the number of patients in whom buprenorphine...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.